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There is an urgent demand for long term solutions to improve osteoarthritis treatments in the ageing population. There are
drugs that control the pain but none that stop the progression of the disease in a safe and eﬃcient way. Increased intervention
eﬀorts, augmented by early diagnosis and integrated biophysical therapies are therefore needed. Unfortunately, progress has been
hampered due to the wide variety of experimental models which examine the eﬀect of mechanical stimuli and inflammatory
mediators on signal transduction pathways. Our understanding of the early mechanopathophysiology is poor, particularly the
way in which mechanical stimuli influences cell function and regulates matrix synthesis. This makes it diﬃcult to identify
reliable targets and design new therapies. In addition, the eﬀect of mechanical loading on matrix turnover is dependent on the
nature of the mechanical stimulus. Accumulating evidence suggests that moderate mechanical loading helps to maintain cartilage
integrity with a low turnover of matrix constituents. In contrast, nonphysiological mechanical signals are associated with increased
cartilage damage and degenerative changes. This review will discuss the pathways regulated by compressive loading regimes and
inflammatory signals in animal and in vitro 3D models. Identification of the chondroprotective pathways will reveal novel targets
for osteoarthritis treatments.
1. Introduction
It is well established that mechanical loading regulates
the structure and function of musculoskeletal tissues and
helps maintain the functional integrity of articular car-
tilage and joint homeostasis. The onset and progression
of osteoarthritis (OA) involves all the tissues of the joint
initiated by multiple risk factors. These include joint
instability and/or misalignment, obesity, previous knee
injury, muscle weakness, age, and genetics. It is clear that
joint tissues are sensitive to the magnitude, duration, and
nature of the mechanical stimulus. A range of approaches
have, therefore, been developed to examine the eﬀect of
mechanical loading on cartilage homeostasis and OA disease
progression. However, each approach has limitations which
make it diﬃcult to evaluate the physiological relevance of the
experimental findings. This review article will examine the
role of abnormal joint loading in cartilage destruction and
compare the findings to the protective eﬀects of physiological
loading in animal and in vitro models. In addition, we
will discuss the intracellular mechanisms which mediate
the eﬀects of mechanical loading and explore the potential
of using controlled exercise therapy in combination with
novel agents as an integrated biophysical approach for OA
treatments.
2. Influence of Nonphysiological Mechanical
Loading and Cartilage Destruction
2.1. Joint Overuse and Excessive Mechanical Loading Is Dam-
aging to the Tissue. Cartilage defects in the knees of young or
active individuals remain a problem in orthopaedic practice.
The clinical symptoms of OA are joint pain, limitation
of range of motion, and joint stiﬀness. Sports activities
involving high intensity and repetitive loads increase the risk
of OA and are most often associated with other injuries
such as knee ligament tears, meniscal injuries, patellae
fractures, and osteochondral lesions [1–3]. Cartilage degen-
eration can develop from direct traumas, joint instability
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and misalignment, as a result of altered patterns of load
distribution across the joint [4].
Overloading (e.g., traumatic or high intensity) induces
morphological, molecular, and mechanical changes in cells
and matrix which leads to softening, fibrillation, ulceration,
and loss of cartilage [5–7]. These molecular and biomechan-
ical changes have been shown to shift the balance of tissue
remodelling in favour of catabolic over anabolic activity in
animal models. However, studies which measure the eﬀects
of mechanical loading on cartilage due to overuse in human
joints are few in number. By contrast, there are a plethora
of experimental studies which have examined the eﬀect
of overloading in animal and 3D models (Table 1). For
example, strenuous exercise in a canine model caused by
running either 20 or 40 km/day for up to 15 weeks reduced
proteoglycan content in the superficial zone of cartilage,
increased water content, and decreased the concentration
of collagen in the load-bearing region [8, 9]. In rodents,
enforced running of mice for 1 km/day, or a sudden increase
in exercise at an older age resulted in more severe cartilage
lesions than observed in sedentary controls [10, 11].
In vitro studies have identified a critical stress threshold
of 15–20MPa above which cell death and collagen damage
was evident due to a single impact load in bovine cartilage
explants [12, 13]. In a separate study, apoptosis occurred
at peak stresses as low as 4.5MPa followed by collagen
degradation at 7 to 12MPa and nitrite accumulation at
20MPa [14]. However, the source of the tissue tested and
nature of the impact load will certainly influence the type
and extent of damage [15]. For example, human cartilage
was found to be more resistant to damage than bovine
tissue following a single impact load of similar magnitude
[16]. This may be due to the structural diﬀerences between
the two tissue types and cartilage thickness or eﬀects of
age-accumulated changes observed in samples from older
patients. Furthermore, impact damage is inevitably strain
rate dependent. Indeed, in a comparative study, low strain
rates had no discernable eﬀect on matrix synthesis in bovine
cartilage explants, whereas strain rates up to twofold higher
decreased the levels of proteoglycans, and hence reduced
both compressive and shear stiﬀness [17]. The damage
caused by repeated impact loading was cumulative in nature,
initially inducing necrosis, followed by apoptosis and colla-
gen degradation in cartilage explants [18, 19]. In addition,
the application of static load, equivalent to a compressive
strain of 50%, decreased the synthesis of both collagen type
II and proteoglycans in bovine cartilage explants [20–22].
Taken together, these experimental findings demonstrate
that if joints are insuﬃciently loaded, cartilage metabolism
shifts in favour of catabolism, essentially leading to tissue
atrophy. Long-term injurious mechanical loading, which
represent high levels of peak stress and/or strain rates,
induces abnormal compositional changes in cartilage and
accelerates breakdown of the extracellular matrix. How-
ever, the magnitude of loads reported in vitro may not
replicate the in vivo loading environment. This limitation
makes it diﬃcult to identify the range of nonphysiological
loading modalities that are likely to be encountered in
a clinical setting. Accordingly, clinical studies of critical
patient populations may provide more appropriate means of
evaluating the physiological relevance of mechanical factors
on integrated disease pathways and treatments.
2.2. Reduced Joint Loading and Disuse Leads to Cartilage
Degeneration. Reduced joint loading (e.g., static and immo-
bilisation) leads to atrophy and degeneration of cartilage
(Table 1). Indeed, animal studies demonstrate that pro-
longed joint immobilisation causes cartilage thinning, tissue
softening, and reduced proteoglycan content resulting in
matrix fibrillation, ulceration, and erosion [23–25]. An
inactive lifestyle leads to OA like changes in a hamster
model, as characterised by reduced proteoglycan content,
fibrillation, pitting, and fissuring [26]. In clinical studies,
patients with fractures and partial or complete immobili-
sation presented significant temporal changes in cartilage
morphology, including reduced thickness in the femorotibial
joint compared to the patella [27]. In the absence of joint
loading, patients with spinal cord injuries showed progres-
sive thinning of knee cartilage in the absence of normal joint
loading at a rate which was higher than that observed in OA
[28, 29]. However, the loss of proteoglycans following short-
term immobilisation in a canine model was largely reversible
and remobilisation of the joint led to restoration of matrix
[30–32]. This eﬀect may be possible, since the loading condi-
tion primarily aﬀects the proteoglycan content and does not
irreversibly influence the collagen network. However, if the
animal is actively exercised at the time of remobilisation, the
integrity of the tissue will be compromised, suggesting that
prolonged immobilisation may cause irreversible damage to
the tissue [33–35].
3. Physiological Mechanical Stimuli
and Cartilage Homeostasis
3.1. Moderate Mechanical Loading Plays a Role in Normal
Tissue Remodelling. Several investigators have used a range
of approaches to examine the eﬀect of moderate exercise in
maintaining cartilage homeostasis (Table 2). Indeed, there is
sound evidence that individuals engaging in regular activity
are less prone to incidence of OA, since frequent dynamic
loading in the physiological range will increase cartilage
thickness and maintain normal cartilage integrity [36, 37].
There is also evidence that exercise therapy in the form of
aerobic and strengthening activities reduced pain and dis-
ability, enhances GAG content, and protects against cartilage
degeneration in subjects with knee OA [4, 38–41]. However,
the protective eﬀect of recreational exercise has been reported
to be dependent on a number of risk factors including
age, body mass index, history of knee injury, smoking,
and education [42–44]. Clinical observations suggest that
healthy subjects as well as OA patients, in general, can
pursue a high level of physical activity, provided that the
activity is not painful and does not predispose to trauma
[45]. However, there is still insuﬃcient information which
provides useful guidelines on optimal exercise regimen,
dosage, or length of intervention, particularly in overweight
individuals [46]. It is interesting to note that prospective
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cohort studies which examined the eﬀect of exercise on
cartilage properties have reported contradictory results [4,
37]. In some patients, the intervention oﬀered pain relief
and improvements in physical functioning, but in middle-
aged or elderly persons without OA, recreational exercise
neither protects against nor increases risk of the disease
[42, 43, 47–49]. It is inevitable that comparison of findings
between clinical studies, is problematic, as they often involve
diﬀerences in both diagnostic criteria and variable exercise
regimens. However, it is certain that understanding the
associations between risk factors and benefits of physical
activity will provide key information that will have important
implications for clinical practice.
In most animal studies, load bearing exercise minimises
the development of OA. For example, daily exercise increased
proteoglycan content and cartilage thickness in hamster and
rodent models [26, 50]. In dogs, moderate exercise augments
GAG content particularly in younger animals [51, 52]. In
hamsters, early joint loading advances the maturation of
matrix proteins, improved the integrity of the collagen
network and the tissue resistance against OA in older animals
[53–56]. In general, exercise and loading of joints within
a physiological range appears to have beneficial eﬀects
over normal day to day activities characterised by modest
movement. The anabolic changes induced by exercise appear
to enhance the load bearing properties of cartilage and may
help explain how lifelong physical activity protects the joint
from OA during later periods in life.
Several in vitro studies have examined the eﬀect of
physiological mechanical loading on chondrocyte function
and matrix synthesis (Table 3). Indeed, stretching of cells
in monolayer cultures and compression of chondrocytes
in hydrogels or explants generally leads to anabolic sig-
nalling cascades and protective eﬀects. For example, aggrecan
and collagen type II gene expression was increased by
cyclic pressure-induced strain, hydrostatic pressure or fluid-
induced shear stress in chondrocyte monolayers [57–59]. In
agarose, dynamic compression at low frequencies increased
cell proliferation and proteoglycan synthesis following 2
or 21 days of stimulation [60–63]. In cartilage explants,
cyclic compression at frequencies of 0.01 to 1Hz increased
proteoglycan synthesis and gene expression of extracellular
matrix constituents, aggrecan, fibronectin and cartilage
oligomeric matrix protein (COMP) [20, 22, 64–66]. How-
ever, results from in vitro studies are variable and appear to be
dependent on the duration and type of compression regime
employed and whether loading was applied during early or
late cultures [60, 67–70]. In addition, direct comparison
may prove diﬃcult between findings from 3D biomaterial
constructs and explant cultures, since both systems have
inherent disadvantages. For example, 3D agarose models
do not replicate the physiological loading environment of
cartilage and are generally cultured for relatively short time
periods (hours to weeks). For explants, it is diﬃcult to
separate the contribution of the multiple mechanical and
physiochemical changes which influence the intracellular
pathways and regulate cell function in a spatial and temporal
manner. In contrast, in vivo animal models facilitate long-
term studies within a physiologically relevant environment.
However, such models are limited in terms of translating the
findings to humans. Nevertheless, information regarding the
importance of defining the optimal mechanical parameters
required for mechanical conditioning and biosynthesis of
anabolic proteins still needs to be established.
4. Nonphysiological Mechanical Stimuli
and Cartilage Destruction
4.1. Abnormal Mechanical Loading Eﬀects on Signal Trans-
duction Pathways. Chondrocytes will respond to excessive
mechanical signals by disrupting the composition and
structure of the extracellular matrix which reduces the
biomechanical integrity of cartilage. Previous in vitro studies
have demonstrated that mechanical loading, representing an
injurious or traumatic response, activates the integrin recep-
tors which stimulate stress-induced intracellular pathways,
leading to the production of proinflammatory cytokines
such as interleukin-1 (IL-1) and tumour necrosis factor-α
(TNFα). These cytokines disturb the normal remodelling
activities of chondrocytes by increasing production of pro-
teolytic enzymes such as matrix metalloproteinases (MMPs)
and aggrecanases (ADAMTS), a process mediated by nitric
oxide (NO), prostaglandin E2 (PGE2) and reactive oxygen
species (ROS) [71–74]. Furthermore, the enhanced levels of
proteinase enzymes cleave both collagens and proteoglycans,
resulting in an increase in matrix fragments which stimulate
abnormal integrin signals. The accumulation of matrix frag-
ments enhance catabolic protease-driven pathways that over-
ride anabolic events and contribute to eventual loss of matrix
components and structural damage [75–79]. Abnormal
mechanical stimuli are likely to contribute to matrix damage
which might shift balance of cell metabolism and lead to the
onset of OA. In a recent study, surgical joint destabilisation
in rodents for four weeks resulted in an increased expression
of TGFβ2, insulin like growth factor-binding protein (IGF-
BP), MMP-2, 12, 13 and 14, ADAMTS5, Toll-like receptor 2
(TLR-2), prostaglandin E synthase (PGES), tumour necrosis
factor-stimulated gene 6 (TSG-6), and Wnt-16 [80]. The
animal model represents early OA tissue and is in agreement
with microarray studies, which revealed changes in MMP-
13, COL2A1, and ADAMTS5 in OA cartilage [81, 82]. In
addition, several surgical, transgenic or knockout mouse
models have provided rapid insights into the mechanisms
that control disease progression [83]. In mice, ADAMTS4/5
double knockout and reduced discoidin domain receptor
2 (DDR-2) activation prevents OA progression [84–86].
However, these studies did not provide any information on
the mechanical load-induced eﬀects making it diﬃcult to
correlate the findings with human disease.
Recent studies utilised a dietary model of obesity to
examine the combined eﬀect of mechanical overload and
inflammatory mediators in cartilage degeneration [87, 88].
C57BL/6J mice fed with a high-fat diet increased serum levels
of leptin, adiponectin and IL-1α leading to degenerative
changes observed in knee OA [89]. The studies in mice
correlate with clinical findings which found elevated levels
of leptin, adiponectin, and resistin in osteoarthritic synovial
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fluid [90, 91]. The adipokine levels were found to correlate
with body mass index and were greater in female subjects,
indicating a high prevalence of OA in women [91, 92].
In vitro studies demonstrate dose-dependent catabolic and
anabolic eﬀects of leptin in chondrocytes, leading to matrix
remodelling and/or breakdown. Leptin synergises with IL-1
and was shown to increase NO production leading to MMP
activation, apoptosis, and matrix degradation [93, 94]. Fur-
thermore, leptin activates the RhoA/ROCK pathway leading
to LIMK1 and cofilin-2 phosphorylation and cytoskeletal
re-organisation in chondrocytes [95]. Taken together, these
findings indicate that both obesity and mechanical overload
influences normal chondrocyte function and contributes to
an increase in the incidence and rate of progression of OA.
A number of in vitro models have been developed, which
examine the eﬀects of various compression regimens on
signal transduction pathways. In cartilage explants, 50%
static compression for 24 hours increased expression of
MMP-3, 9, and 13 and reduced aggrecan and collagen type
II within 1 to 2 hours following loading [96–99]. The down-
regulation of matrix components by static compression was
mediated by the interleukin-1 (IL-1) receptor and involves
activation of members of the mitogen activation protein
kinase (MAPK) family. Static compression diﬀerentially
stimulates activation of extracellular signal-regulated kinase
1/2 (ERK 1/2), p38 MAPK and SAPK/ERK kinase-1 (SEK1)
in a time-dependent manner [96, 100–103]. Several studies
demonstrate that IL-1 will additionally stimulate the MAPK
pathway and increaseMMP levels which reduce proteoglycan
synthesis in chondrocytes [104–106]. Both IL-1 and static
compressionmay, therefore, share a global pathway and elicit
a catabolic response mediated by members of the MAPK
family. However, MAPK activation by static compression was
most often transient and was reported to be dependent on
the magnitude of applied stress and duration of load [100].
In contrast, cyclic compression for 30min activates ERK 1/2
and JNK, increased AP-1 binding and expression of MMP-
3 and 13, leading to an increase in matrix components in
chondrocytes cultured on a calcium polyphosphate substrate
[107]. The sequential activation of the MAPK, AP-1, and
MMP pathway occurred before matrix degradation and sug-
gests that short-term continuous compression may induce
tissue remodelling via these signalling mediators.
The pathways of interactions between non-physiological
mechanical signals and inflammatory cytokines will, there-
fore, involve a number of signalling routes (Figure 1). The
actin cytoskeleton plays an important role in mediating
the eﬀects of mechanical stimuli on nuclear deformation
and cell metabolism. Remodelling of the actin cytoskeleton
and disruption of the focal adhesion network leads to focal
adhesion kinase (FAK) and Src activation, which stimulate
the MAPK cascade. Disruption of the golgi apparatus and
cytoskeletal proteins by static compression results in overall
loss of mechanical properties leading to a reduction in
aggrecan and collagen type II gene expression [108–114].
Tensile or compressive loading at high magnitudes (10 to
15%) for longer periods increased expression of MMP-1,
3, 9, IL-1β, and TNFα and production of NO and PGE2
[115–117]. Upregulation of the inducible nitric oxide syn-
thase (iNOS) and cyclo-oxygenase-2 (COX-2) enzymes will
lead to several eﬀects in chondrocytes including increased
cytokine production, MMP activation, ROS production, and
apoptosis [118–121]. The induction of cell death by fluid-
induced shear stress involves protein kinase (PKB) activation
and suppression of phosphatidylinositol 3-kinase (PI3-K),
which inhibits antioxidant capacity leading to apoptosis
[122, 123]. In addition, exposure of T/C-28a2 chondrocytes
to high levels of shear stress increased PGE2 production
and IL-6 expression leading to matrix degradation and
chondrocyte apoptosis [124, 125]. The induction of IL-6 was
time and magnitude dependent and involved cAMP, protein
kinase A (PKA), and PI3-K/Akt-dependent NFκB activation.
Prolonged application of shear stress for up to 72 hours
increased expression of IL-1β, COX-2 and L-prostaglandin
D synthase (L-PGDS) leading to ROS production and
matrix degradation in T/C-28a2 cells [126]. Furthermore,
injurious cyclic or impact loading increased fibronectin
synthesis, MMP-3 gene expression, collagen damage, and
proteoglycan breakdown in cartilage explants [127, 128].
Overall, these studies demonstrate that the expression of
proteins involved in matrix remodelling and catabolism
dominate over anabolic signalling events in chondrocytes
subjected to abnormal mechanical stimuli.
5. Chondroprotective Effects of
Mechanical Loading
5.1. Signalling Pathways Activated by Physiological Mechanical
Stimuli. Evidence from in vitro studies demonstrate that
mechanical signals within a physiological range of intensity,
duration and frequency have potent anti-inflammatory
eﬀects which counteract the catabolic signals induced by IL-
1β or TNFα (Figure 2). For example, cyclic tensile strain of
low magnitudes (3 to 8%) at 0.25Hz inhibits the expression
of iNOS, COX-2, MMP-9 and 13 and increased TIMP-
II synthesis in chondrocyte monolayers cultured with IL-
1β [129]. The downregulation of the catabolic genes by
cyclic tensile strain leads to the reduction of NO and
PGE2 levels and increased synthesis of GAGs, aggrecan and
collagen type II [117, 130, 131]. In chondrocytes cultured
in agarose constructs, 15% dynamic compression at 1Hz
counteracts IL-1β-induced iNOS and COX-2 expression
and production of NO and PGE2 [132, 133]. Tensile and
compressive loading inhibit the nuclear factor-kappa B
(NFκB) signal transduction pathway leading to a suppression
of iNOS, COX-2, and MMP gene expression [134, 135].
Mechanical stimuli may inhibit cytoplasmic dissociation of
NFκB from inhibitory κB-α (IκB-α), which prevents nuclear
translocation of the p65/p50 dimers and/or proteolytic
degradation of IκB-α by two IκB-specific kinases (IKKα and
IKKβ). This eﬀect switches oﬀ transcription for the pro-
inflammatory genes. Both IL-1β and mechanical stimuli
interferes with the NFκB cascade and either aggravates or
counteracts the induction of several catabolic genes induced
by IL-1β. However, a noticeable response in the mechanical
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Figure 1: Eﬀect of nonphysiological mechanical stimuli on signal transduction pathways in chondrocytes. Overloading activates the α5β1
integrin which disrupts the actin cytoskeletal network and stimulates members of the nuclear factor-kappa B (NFκB) and mitogen activated
protein kinase (MAPK) family. These factors increase the production of nitric oxide (NO), proteolytic enzymes (MMP-1, 3, 8, and 13),
ADAMTS (4 and 5), reactive oxygen species (ROS), cytokines (IL-1, TNFα), and prostaglandins (PGE2), which mediate cartilage damage.
Mechanical signals may indirectly interact with the stretch-activated ion channels (SACs) or increase intracellular calcium levels, which
stimulate caspase production (3 and 9) leading to apoptosis. The protease enzymes increase catabolic activities and accelerate tissue damage
via production of fibronectin (FN-fs) or collagen fragments (Col-fs), which bind to the integrins, annexin V, discoidin domain receptor 2
(DDR-2), and induce cytokines. Reduced loading (e.g., static and immobilisation) stimulates the IL-1 receptor which activates ERK1/2, AP-1
and MMPs leading to reduced aggrecan and collagen type II synthesis.
loading studies was the partial eﬀect of NFκB inhibitors on
downregulating the pro-inflammatory response. The gene
expression data, therefore, support NFκB-dependent and
independent mechanisms, suggesting cross-talk with other
pathways. For instance, a number of overlapping genes
are regulated by the NFκB and MAPK signal transduction
pathways. However, the precise sequence of events which lead
to alterations in NFκB or MAPK activity by physiological
mechanical signals have yet to be fully explored.
The critical mechanosensitive components include the
integrins and cytoskeletal proteins (Figure 2). Previous in
vitro studies have shown a role for the integrins in mediating
the compression-induced synthesis of matrix components
[136–140]. Perturbation of the cell membrane induces
integrin conformational changes which promote binding to
adaptor proteins (e.g., talin, vinculin, α-actinin, paxillin, and
zyxin) and interactions with other membrane receptors such
as growth factors and stretch-activated ion channels (SACs).
The adaptor proteins form the focal adhesion complex which
links the integrins to the contractile microfilament bundles,
thereby forming amolecular bridge between the extracellular
matrix and the cytoskeleton. An intact cytoskeleton is
required for normal mechanotransduction and mediates
phosphorylation of FAK, paxillin, and Src leading to MAPK
activation or secretion of interleukin-4 (IL-4) [137, 138, 141–
143]. Substance P is upstream of IL-4 and may act through
the NK1 receptor, thereby inducing IL-4 release. It is plausi-
ble that IL-4 released through an integrin-mediated mechan-
otransduction pathway will accumulate and contribute to
a pool of soluble anti-inflammatory mediators which block
signals induced by IL-1β. For example, compressive loading
and/or stimulation with IL-4 counteracts IL-1β induced NO
and PGE2 production, MMP-13 expression and stimulates
matrix synthesis [144, 145]. Physiological mechanical signals
may, therefore, increase the transport of soluble factors
which enhance the chondroprotective eﬀects in cartilage.
Moreover, mechanical stimuli may induce ERK due to
the release of basic fibroblast growth factor (FGF-2) or cause
cell membrane hyperpolarisation leading to an influx of
calcium or sodium ions through putative mechanosensitive
ion channels [141, 146, 147]. It is possible that membrane
deformation induces colocalisation of ion channels with
integrin clusters and cytoskeletal complexes resulting in
activation of downstream signalling events. For example,
the entry of calcium through mechanosensitive ion channels
will influence the activity of the constitutive isoform of
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Figure 2: Model depicting the potential protective eﬀects of physiological mechanical stimuli in chondrocytes stimulated with interleukin-
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cytoplasmic dissociation of NFκB from inhibitory κB-α (IκB-α), which prevents nuclear translocation of the p65/p50 dimers and/or
proteolytic degradation of IκB-α by IκB-specific kinases (IKK) or impair IκB-α degradation, thereby switching oﬀ transcription for the
pro-inflammatory genes.
NOS (cNOS) and regulate calcium/calmodulin binding,
PLC/IP3 activation, NO production, and aggrecan gene
expression [141, 148, 149]. In contrast, the stability of
iNOS mRNA has been reported to be reduced by increased
calcium, suggesting a possible anabolic route which blocks
IL-1β-induced signals [150]. Previous studies demonstrate
the involvement of a purinergic pathway in mediating
mechanical load-induced ATP release and stimulation of
anabolic activities [151, 152]. The enhanced ATP levels
increased cyclic AMP by adenylate cyclase leading to changes
in gene expression [96]. In microarray studies, the increased
levels of BMP-2, inhibin βA/activin and prostaglandins
suggest a possible protective mechanism [82]. Furthermore,
the cAMP-responsive element-binding protein (CBP)/p300-
interacting transactivator with ED-rich tail 2 (CITED2)
has chondroprotective eﬀects and mediates suppression of
MMPs in C28/I12 chondrocytes subjected to moderate
shear stress or hydrostatic pressure by competing with the
transcription factor, Ets-1 [153, 154]. In rodents, one hour
of daily passive motion inhibits MMP-1 expression and
upregulates CITED2 [154]. These studies clearly identify a
number of routes involved in chondroprotection and are
illustrated in Figure 2.
6. Future Therapies by Combined Exercise
and Chondroprotective Agents
The need for novel pharmacological agents which provide
eﬀective long-term pain relief and have disease modifying
properties for OA treatments is, as yet, unmet. Direct
delivery of drugs such as glucocorticoid and hyaluronic acid
formulations into the aﬀected joint, do not retard the disease
process and may provide only short-term pain relief [155].
The development of novel drugs such as lipid-based for-
mulations and nanoparticles in combination with controlled
exercise therapy may provide an alternative strategy in this
challenging area of research. Such therapies may be aimed
at blocking the pro-inflammatory and proteolytic pathways,
thereby allowing the beneficial eﬀects of targeted anabolic
exercise regimens. Experimental studies suggest that such
options may be of value. For example, intra-articular injec-
tion of the IL-1 receptor antagonist (IL-1Ra) was reported
to block IL-1β actions and reduce OA disease progression
in a canine OA model [156]. In rodents, intra-articular
injection of IL-4 decreased NO production and prevents
cartilage breakdown, whilst in cartilage explants and agarose,
growth factors such as IGF-1 or TGFβ in combination with
10 Arthritis
mechanical stimuli enhance matrix synthesis [144, 145, 157–
159]. Furthermore, intra-articular injection of leptin in the
rat knee joint stimulates proteoglycan synthesis via increased
production of IGF-1 and TGFβ1 [92]. The combined eﬀect of
exercise therapy in conjunction with these chondroprotective
agents is not known and merits further investigation.
A further option is to develop agents which synergise
with physiological mechanical loading or which block the
signal transduction pathways activated by abnormal me-
chanical stimuli. Stimulation of mechanoreceptors releases
several soluble mediators in chondrocytes including ROS,
prostaglandins, cytokines, growth factors, and neuropep-
tides. These mediators activate downstream signalling events
that regulate gene expression and cell function. For exam-
ple, anti-inflammatory cytokines (IL-4 and IL-10), growth
factors (TGFβ, IGF-1, and FGF-2) and transcriptional
regulators (CITED2) synergise with mechanical stimuli and
enhance the production of matrix components [144, 145,
154, 160]. Furthermore, physiological mechanical signals
antagonise the eﬀects of catabolic mediators involving
pro-inflammatory cytokines (IL-1β), transcription factors
(NFκB), MAPKs, and enzymes (NOS, COX, and MMPs)
[133–135, 161, 162]. Mechanical stimulation will increase
tension at the cell surface and activate the integrins which
are bound to several matrix proteins. Blocking integrin
function with antibodies or small molecules has been shown
to decrease oxidative damage and improve neurological func-
tion following spinal cord injury [163]. Targeting specific
ion channels will allow modification of the cells response
since mechanical stimuli diﬀerentially activates ion channels
in normal and OA chondrocytes. Indeed, as the chondrocyte
channelome becomes better defined and the roles for
these molecules in regulating mechanotransduction become
clearer, an increase in the range of potential therapeutic
targets will emerge. In this context, N-methyl-D-aspartic
acid receptor (NMDAR) may be a novel therapeutic target
for OA. NMDAR appears to be necessary for mechanical
signalling events in normal and OA chondrocytes [164,
165]. However, the downstream responses are diﬀerent.
In normal chondrocytes, NMDAR mediates mechanical
loading-induced activation of small conductance calcium-
dependent sodium (SK) channels. In OA chondrocytes,
mechanical stimuli opens tetrodotoxin sensitive sodium
channels leading to inflammatory gene expression. NMDAR
antagonists which block the pro-inflammatory eﬀect are
being developed for the treatment of diseases in the central
nervous system and drugs such as Memantine are used clin-
ically. Thus, agents which specifically target the functional
distinct subtypes of NMDAR will have preferential eﬀects in
peripheral tissues and could block mechanical signal induced
catabolic pathways.
In addition, matrix deformation will cause bending of
the primary cilia which stimulates connexin 43 (Cx43)
hemichannels leading to ATP release and purinergic receptor
activation [166, 167]. Deficiency in either the P2X or P2Y
receptors will result in reduced responsiveness to mechanical
signals leading to new pathways which are catabolic and,
therefore, compromise tissue structural properties [168].
Overall, these studies provide further insights on the critical
mediators which could be used to promote mechanotherapy
for OA. However, pharmacological intervention strategies
which either antagonise or enhance the mechanotrans-
duction process are likely to prove diﬃcult. Normal and
OA chondrocytes from diseased joints transmit mechanical
signals via the α5β1 integrin, resulting in markedly diﬀerent
downstream signalling events. For example, mechanical
stimulation of normal chondrocytes release the chondropro-
tective IL-4 in contrast to OA cells which produce IL-1β
[169]. It is possible that chondrocytes from OA cartilage
have been reprogrammed to respond diﬀerently to their
altered mechanical environment, and it may be necessary to
target structural components of the cell such as the actin
cytoskeleton [170]. This may allow reversal of biomechanical
changes developed during OA disease progression allowing
the beneficial eﬀects of moderate exercise to be gained at the
tissue level.
7. Conclusions
The importance of mechanical loading in maintaining
healthy joints and normal tissue remodelling has long been
recognised. Previous in vitro studies continue to support the
hypothesis that moderate mechanical loading is necessary to
maintain healthy cartilage. If joints are insuﬃciently loaded,
chondrocyte metabolism shifts in favour of catabolism.
Similarly, traumatic or excessive joint loading leads to
cartilage degeneration and OA. Emerging evidence suggests
that physiological joint loading could be used to counteract
the inflammatory pathways and restore anabolic activities.
Further investigations into the chondroprotective mecha-
nisms are likely to be highly informative and will reveal novel
therapeutic targets for OA treatments.
Acknowledgments
The authors would like to acknowledge funding from the AO
Research Fund of the AO Foundation (S-09-83-C) and the
Arthritis Research UK (19646 and 17026).
References
[1] J. A. Buckwalter and N. E. Lane, “Athletics and osteoarthri-
tis,” American Journal of Sports Medicine, vol. 25, no. 6, pp.
873–881, 1997.
[2] C. Stehling, A. Luke, R. Stahl et al., “Meniscal T1rho and T2
measured with 3.0T MRI increases directly after running a
marathon,” Skeletal Radiology, pp. 1–11, 2010.
[3] T. D. Spector and D. J. Hart, “Radiological evaluation of
osteoarthritis,” Revue du Praticien, vol. 46, no. 19, pp. S15–
S21, 1996.
[4] E. M. Roos and L. Dahlberg, “Positive eﬀects of moderate
exercise on glycosaminoglycan content in knee cartilage: a
four-month, randomized, controlled trial in patients at risk
of osteoarthritis,” Arthritis and Rheumatism, vol. 52, no. 11,
pp. 3507–3514, 2005.
[5] E. L. Radin, M. G. Ehrlich, R. Chernack, P. Abernethy, I. L.
Paul, and R. M. Rose, “Eﬀect of repetitive impulsive loading
on the knee joints of rabbits,” Clinical Orthopaedics and
Related Research, vol. 131, pp. 288–293, 1978.
Arthritis 11
[6] C. Muehleman, D. Bareither, K. Huch, A. A. Cole, and
K. E. Kuettner, “Prevalence of degenerative morphological
changes in the joints of the lower extremity,” Osteoarthritis
and Cartilage, vol. 5, no. 1, pp. 23–37, 1997.
[7] H. J. Mankin and J. A. Buckwalter, “Restoration of the
osteoarthrotic joint,” The Journal of Bone and Joint Surgery,
vol. 78, no. 1, pp. 1–2, 1996.
[8] I. Kiviranta, M. Tammi, J. Jurvelin, J. Arokoski, A. M.
Saamanen, and H. J. Helminen, “Articular cartilage thickness
and glycosaminoglycan distribution in the canine knee joint
after strenuous running exercise,” Clinical Orthopaedics and
Related Research, no. 283, pp. 302–308, 1992.
[9] J. Arokoski, I. Kiviranta, J. Jurvelin, M. Tammi, and H.
J. Helminen, “Long-distance running causes site-dependent
decrease of cartilage glycosaminoglycan content in the knee
joints of beagle dogs,” Arthritis and Rheumatism, vol. 36, no.
10, pp. 1451–1459, 1993.
[10] T. Lapvetelainen, T. Nevalainen, J. J. Parkkinen et al.,
“Lifelong moderate running training increases the incidence
and severity of osteoarthritis in the knee joint of C57BL
mice,” Anatomical Record, vol. 242, no. 2, pp. 159–165, 1995.
[11] J. P. A. Arokoski, J. S. Jurvelin, U. Va¨a¨ta¨inen, and H.
J. Helminen, “Normal and pathological adaptations of
articular cartilage to joint loading,” Scandinavian Journal of
Medicine and Science in Sports, vol. 10, no. 4, pp. 186–198,
2000.
[12] P. A. Torzilli, R. Grigiene, J. Borrelli Jr., and D. L. Helfet,
“Eﬀect of impact load on articular cartilage: cell metabolism
and viability, and matrix water content,” Journal of Biome-
chanical Engineering, vol. 121, no. 5, pp. 433–441, 1999.
[13] J. E. Jeﬀrey, D. W. Gregory, and R. M. Aspden, “Matrix
damage and chondrocyte viability following a single impact
load on articular cartilage,” Archives of Biochemistry and
Biophysics, vol. 322, no. 1, pp. 87–96, 1995.
[14] A. M. Loening, I. E. James, M. E. Levenston et al., “Inju-
rious mechanical compression of bovine articular cartilage
induces chondrocyte apoptosis,” Archives of Biochemistry and
Biophysics, vol. 381, no. 2, pp. 205–212, 2000.
[15] R. M. Aspden, J. E. Jeﬀrey, and L. V. Burgin, “Impact loading
of articular cartilage,”Osteoarthritis and Cartilage, vol. 10, no.
7, pp. 588–590, 2002.
[16] J. E. Jeﬀrey and R. M. Aspden, “The biophysical eﬀects of a
single impact load on human and bovine articular cartilage,”
Proceedings of the Institution of Mechanical Engineers H, vol.
220, no. 6, pp. 677–686, 2006.
[17] B. Kurz, M. Jin, P. Patwari, D. M. Cheng, M. W. Lark, and
A. J. Grodzinsky, “Biosynthetic response and mechanical
properties of articular cartilage after injurious compression,”
Journal of Orthopaedic Research, vol. 19, no. 6, pp. 1140–1146,
2001.
[18] C. T. Chen, N. Burton-Wurster, G. Lust, R. A. Bank, and
J. M. Tekoppele, “Compositional and metabolic changes in
damaged cartilage are peak- stress, stress-rate, and loading-
duration dependent,” Journal of Orthopaedic Research, vol.
17, no. 6, pp. 870–879, 1999.
[19] C. T. Chen, N. Burton-Wurster, C. Borden, K. Hueﬀer, S. E.
Bloom, and G. Lust, “Chondrocyte necrosis and apoptosis in
impact damaged articular cartilage,” Journal of Orthopaedic
Research, vol. 19, no. 4, pp. 703–711, 2001.
[20] F. Guilak, B. C. Meyer, A. Ratcliﬀe, and V. C. Mow, “The
eﬀects of matrix compression on proteoglycan metabolism
in articular cartilage explants,” Osteoarthritis and Cartilage,
vol. 2, no. 2, pp. 91–101, 1994.
[21] R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H.
K. Plaas, and J. D. Sandy, “Biosynthetic response of cartilage
explants to dynamic compression,” Journal of Orthopaedic
Research, vol. 7, no. 5, pp. 619–636, 1989.
[22] Y. J. Kim, A. J. Grodzinsky, and A. H. K. Plaas, “Compression
of cartilage results in diﬀerential eﬀects on biosynthetic path-
ways for aggrecan, link protein, and hyaluronan,” Archives
of Biochemistry and Biophysics, vol. 328, no. 2, pp. 331–340,
1996.
[23] M. Palmoski, E. Perricone, and K. D. Brandt, “Development
and reversal of a proteoglycan aggregation defect in normal
canine knee cartilage after immobilization,” Arthritis and
Rheumatism, vol. 22, no. 5, pp. 508–517, 1979.
[24] J. Jurvelin, I. Kiviranta, M. Tammi, and J. H. Helminen,
“Softening of canine articular cartilage after immobilization
of the knee joint,” Clinical Orthopaedics and Related Research,
no. 207, pp. 246–252, 1986.
[25] J. C. Copray, H. W. B. Jansen, and H. S. Duterloo, “Eﬀects of
compressive forces on proliferation and matrix synthesis in
mandibular condylar cartilage of the rat in vitro,” Archives of
Oral Biology, vol. 30, no. 4, pp. 299–304, 1985.
[26] I. G. Otterness, J. D. Eskra, M. L. Bliven, A. K. Shay,
J. P. Pelletier, and A. J. Milici, “Exercise protects against
articular cartilage degeneration in the hamster,” Arthritis and
Rheumatism, vol. 41, no. 11, pp. 2068–2076, 1998.
[27] S. Hinterwimmer, M. Krammer, M. Kro¨tz et al., “Cartilage
atrophy in the knees of patients after seven weeks of partial
load bearing,” Arthritis and Rheumatism, vol. 50, no. 8, pp.
2516–2520, 2004.
[28] Vanwanseele, F. Eckstein, H. Knecht, E. Stu¨ssi, and A.
Spaepen, “Knee cartilage of spinal cord-injured patients
displays progressive thinning in the absence of normal joint
loading and movement,” Arthritis and Rheumatism, vol. 46,
no. 8, pp. 2073–2078, 2002.
[29] B. Vanwanseele, F. Eckstein, H. Knecht, A. Spaepen, and
E. Stu¨ssis, “Longitudinal analysis of cartilage atrophy in
the knees of patients with spinal cord injury,” Arthritis and
Rheumatism, vol. 48, no. 12, pp. 3377–3381, 2003.
[30] J. Haapala, J. P. A. Arokoski, M. M. Hyttinen et al., “Remo-
bilization does not fully restore immobilization induced
articular cartilage atrophy,” Clinical Orthopaedics and Related
Research, no. 362, pp. 218–229, 1999.
[31] A. M. Saamanen, M. Tammi, J. Jurvelin, I. Kiviranta, and H.
J. Helminen, “Proteoglycan alterations following immobili-
zation and remobilization in the articular cartilage of young
canine knee (stifle) joint,” Journal of Orthopaedic Research,
vol. 8, no. 6, pp. 863–873, 1990.
[32] J. Jurvelin, I. Kiviranta, A. M. Saamanen, M. Tammi, and H.
J. Helminen, “Partial restoration of immobilization-inducing
softening of canine articular cartilage after remobilization of
the knee (stifle) joint,” Journal of Orthopaedic Research, vol.
7, no. 3, pp. 352–358, 1989.
[33] M. J. Palmoski and K. D. Brandt, “Running inhibits the
reversal of atrophic changes in canine knee cartilage after
removal of a leg cast,” Arthritis and Rheumatism, vol. 24, no.
11, pp. 1329–1337, 1981.
[34] J. Haapala, J. Arokoski, J. Pirttima¨ki et al., “Incomplete
restoration of immobilization induced softening of young
beagle knee articular cartilage after 50-week remobilization,”
International Journal of Sports Medicine, vol. 21, no. 1, pp. 76–
81, 2000.
[35] J. A. Buckwalter, “Articular cartilage: injuries and potential
for healing,” Journal of Orthopaedic and Sports Physical
Therapy, vol. 28, no. 4, pp. 192–202, 1998.
12 Arthritis
[36] K. M. Jordan, N. K. Arden, M. Doherty et al., “EULAR
recommendations 2003: rn evidence based approach to
the management of knee osteoarthritis: report of a task
force of the Standing Committee for International Clinical
Studies including therapeutic trials (ESCISIT),” Annals of the
Rheumatic Diseases, vol. 62, no. 12, pp. 1145–1155, 2003.
[37] M. Fransen, S.McConnell, andM. Bell, “Therapeutic exercise
for people with osteoarthritis of the hip or knee. A systematic
review,” Journal of Rheumatology, vol. 29, no. 8, pp. 1737–
1745, 2002.
[38] E. Roddy, W. Zhang, and M. Doherty, “Aerobic walking
or strengthening exercise for osteoarthritis of the knee? A
systematic review,” Annals of the Rheumatic Diseases, vol. 64,
no. 4, pp. 544–548, 2005.
[39] M. J. Jansen, W. Viechtbauer, A. F. Lenssen, E. J. Hendriks,
and R. A. de Bie, “Strength training alone, exercise therapy
alone, and exercise therapy with passive manual mobilisa-
tion each reduce pain and disability in people with knee
osteoarthritis: a systematic review,” Journal of Physiotherapy,
vol. 57, no. 1, pp. 11–20, 2011.
[40] M. J. Jansen, E. J. Hendriks, R. A.B. Oostendorp, J. Dekker,
and R. A. De Bie, “Quality indicators indicate good adherence
to the clinical practice guideline on “Osteoarthritis of the
hip and knee” and few prognostic factors influence outcome
indicators: a prospective cohort study,” European Journal of
Physical and Rehabilitation Medicine, vol. 46, no. 3, pp. 337–
345, 2010.
[41] P. Manninen, H. Riihimaki, M. Heliovaara, and O. Suo-
malainen, “Physical exercise and risk of severe knee OA
requiring arthriplasty,” Rheumatology, vol. 40, no. 4, pp. 432–
437, 2001.
[42] D. T. Felson, J. Niu, C. McClennan et al., “Knee buckling:
prevalence, risk factors, and associated limitations in func-
tion,” Annals of Internal Medicine, vol. 147, no. 8, pp. 534–
540, 2007.
[43] S. P. Messier, “Diet and exercise for obese adults with knee
osteoarthritis,” Clinics in Geriatric Medicine, vol. 26, no. 3,
pp. 461–477, 2010.
[44] S. Perrot, S. Poiraudeau, M. Kabir-Ahmadi, and F. Rannou,
“Correlates of pain intensity in Men and Women with hip
and knee osteoarthritis. Results of a national survey: the
French ARTHRIX study,” Clinical Journal of Pain, vol. 25, no.
9, pp. 767–772, 2009.
[45] E. Vignon, J. P. Valat, M. Rossignol et al., “Osteoarthritis
of the knee and hip and activity: a systematic international
review and synthesis (OASIS),” Joint Bone Spine, vol. 73, no.
4, pp. 442–455, 2006.
[46] K. L. Bennell and R. S. Hinman, “A review of the clinical
evidence for exercise in osteoarthritis of the hip and knee,”
Journal of Science and Medicine in Sport, vol. 14, no. 1, pp.
4–9, 2011.
[47] M. E. van Baar, W. J. J. Assendelft, J. Dekker, R. A. B.
Oostendorp, and J. W. J. Bijlsma, “Eﬀectiveness of exercise
therapy in patients with osteoarthritis of the hip or knee: a
systematic review of randomized clinical trials,” Arthritis and
Rheumatism, vol. 42, no. 7, pp. 1361–1369, 1999.
[48] W. H. Ettinger Jr., R. Burns, S. P. Messier et al., “A
randomized trial comparing aerobic exercise and resistance
exercise with a health education program in older adults with
knee osteoarthritis: the Fitness Arthritis and Seniors Trial
(FAST),” Journal of the American Medical Association, vol.
277, no. 1, pp. 25–31, 1997.
[49] M. W. Creaby, Y. Wang, K. L. Bennell et al., “Dynamic
knee loading is related to cartilage defects and tibial plateau
bone area in medial knee osteoarthritis,” Osteoarthritis and
Cartilage, vol. 18, no. 11, pp. 1380–1385, 2010.
[50] L. Galois, S. Etienne, L. Grossin et al., “Moderate-impact
exercise is associated with decreased severity of experimental
osteoarthritis in rats (multiple letters),” Rheumatology, vol.
42, no. 5, pp. 692–694, 2003.
[51] J. A. Buckwalter, “Osteoarthritis and articular cartilage
use, disuse, and abuse: experimental studies,” Journal of
Rheumatology, vol. 43, pp. 13–15, 1995.
[52] I. Kiviranta, M. Tammi, J. Jurvelin, A. M. Saamanen,
and H. J. Helminen, “Moderate running exercise augments
glycosaminoglycans and thickness of articular cartilage in
the knee joint of young Beagle dogs,” Journal of Orthopaedic
Research, vol. 6, no. 2, pp. 188–195, 1988.
[53] H. J. Helminen, M. M. Hyttinen, M. J. Lammi et al., “Regular
joint loading in youth assists in the establishment and
strengthening of the collagen network of articular cartilage
and contributes to the prevention of osteoarthrosis later in
life: a hypothesis,” Journal of Bone and Mineral Metabolism,
vol. 18, no. 5, pp. 245–257, 2000.
[54] P. Julkunen, J. Iivarinen, P. A. Brama, J. Arokoski, J. S.
Jurvelin, and H. J. Helminen, “Maturation of collagen fibril
network structure in tibial and femoral cartilage of rabbits,”
Osteoarthritis and Cartilage, vol. 18, no. 3, pp. 406–415, 2010.
[55] A. M. Sa¨a¨ma¨nen, M. Tammi, I. Kiviranta, J. Jurvelin, and H.
J. Helminen, “Maturation of proteoglycan matrix in articular
cartilage under increased and decreased joint loading. A
study in young rabbits,” Connective Tissue Research, vol. 16,
no. 2, pp. 163–175, 1987.
[56] P. R. van Weeren, E. C. Firth, H. Brommer et al., “Early
exercise advances the maturation of glycosaminoglycans and
collagen in the extracellular matrix of articular cartilage in
the horse,” Equine Veterinary Journal, vol. 40, no. 2, pp. 128–
135, 2008.
[57] P. Das, D. J. Schurman, and R. L. Smith, “Nitric oxide
and G proteins mediate the response of bovine articular
chondrocytes to fluid-induced shear,” Journal of Orthopaedic
Research, vol. 15, no. 1, pp. 87–93, 1997.
[58] S. J. Millward-Sadler, M. O. Wright, L. W. Davies, G.
Nuki, and D. M. Salter, “Mechanotransduction via integrins
and interleukin-4 results in altered aggrecan and matrix
metalloproteinase 3 gene expression in normal, but not
osteoarthritic, human articular chondrocytes,” Arthritis and
Rheumatism, vol. 43, no. 9, pp. 2091–2099, 2000.
[59] T. Ikenoue, M. C. D. Trindade, M. S. Lee et al., “Mechanoreg-
ulation of human articular chondrocyte aggrecan and type
II collagen expression by intermittent hydrostatic pressure in
vitro,” Journal of Orthopaedic Research, vol. 21, no. 1, pp. 110–
116, 2003.
[60] D. A. Lee and D. L. Bader, “Compressive strains at physio-
logical frequencies influence the metabolism of chondrocytes
seeded in agarose,” Journal of Orthopaedic Research, vol. 15,
no. 2, pp. 181–188, 1997.
[61] D. A. Lee, S. P. Frean, P. Lees, and D. L. Bader, “Dynamic
mechanical compression influences nitric oxide production
by articular chondrocytes seeded in agarose,” Biochemical and
Biophysical Research Communications, vol. 251, no. 2, pp.
580–585, 1998.
[62] R. L. Mauck, M. A. Soltz, C. C. B. Wang et al., “Functional
tissue engineering of articular cartilage through dynamic
loading of chondrocyte-seeded agarose gels,” Journal of
Biomechanical Engineering, vol. 122, no. 3, pp. 252–260, 2000.
[63] M. D. Buschmann, Y. A. Gluzband, A. J. Grodzinsky, and
E. B. Hunziker, “Mechanical compression modulates matrix
Arthritis 13
biosynthesis in chondrocyte/agarose culture,” Journal of Cell
Science, vol. 108, no. 4, pp. 1497–1508, 1995.
[64] J. J. Parkkinen, M. J. Lammi, H. J. Helminen, and M. Tammi,
“Local stimulation of proteoglycan synthesis in articular
cartilage explants by dynamic compression in vitro,” Journal
of Orthopaedic Research, vol. 10, no. 5, pp. 610–620, 1992.
[65] W. B. Valhmu, E. J. Stazzone, N. M. Bachrach et al.,
“Load-controlled compression of articular cartilage induces
a transient stimulation of aggrecan gene expression,” Archives
of Biochemistry and Biophysics, vol. 353, no. 1, pp. 29–36,
1998.
[66] M. Wong, M. Siegrist, and X. Cao, “Cyclic compression
of articular cartilage explants is associated with progressive
consolidation and altered expression pattern of extracellular
matrix proteins,” Matrix Biology, vol. 18, no. 4, pp. 391–399,
1999.
[67] K. Sauerland, R. X. Raiss, and J. Steinmeyer, “Proteoglycan
metabolism and viability of articular cartilage explants
as modulated by the frequency of intermittent loading,”
Osteoarthritis and Cartilage, vol. 11, no. 5, pp. 343–350, 2003.
[68] T. T. Chowdhury, D. L. Bader, J. C. Shelton, and D. A. Lee,
“Temporal regulation of chondrocyte metabolism in agarose
constructs subjected to dynamic compression,” Archives of
Biochemistry and Biophysics, vol. 417, no. 1, pp. 105–111,
2003.
[69] B. Ackermann and J. Steinmeyer, “Collagen biosynthesis of
mechanically loaded articular cartilage explants,” Osteoar-
thritis and Cartilage, vol. 13, no. 10, pp. 906–914, 2005.
[70] J. Steinmeyer, S. Knue, R. X. Raiss, and I. Pelzer, “Eﬀects
of intermittently applied cyclic loading on proteoglycan
metabolism and swelling behaviour of articular cartilage
explants,” Osteoarthritis and Cartilage, vol. 7, no. 2, pp. 155–
164, 1999.
[71] J. C. Fernandes, J. Martel-Pelletier, and J. P. Pelletier,
“The role of cytokines in osteoarthritis pathophysiology,”
Biorheology, vol. 39, no. 1-2, pp. 237–246, 2002.
[72] Y. E. Henrotin, P. Bruckner, and J. P. L. Pujol, “The role of
reactive oxygen species in homeostasis and degradation of
cartilage,” Osteoarthritis and Cartilage, vol. 11, no. 10, pp.
747–755, 2003.
[73] H. A. Kim and F. J. Blanco, “Cell death and apoptosis in
ostearthritic cartilage,” Current Drug Targets, vol. 8, no. 2, pp.
333–345, 2007.
[74] J. Martel-Pelletier, C. Boileau, J. P. Pelletier, and P. J. Rough-
ley, “Cartilage in normal and osteoarthritis conditions,” Best
Practice and Research: Clinical Rheumatology, vol. 22, no. 2,
pp. 351–384, 2008.
[75] G. A. Homandberg, “Potential regulation of cartilage
metabolism in osteoarthritis by fibronectin fragments. In
Fundamental pathways in osteoarthritis. Edited by Malemud
CJ,” Frontiers in Bioscience, pp. 713–730, 1997.
[76] D. L. Xie, F. Hui, and G. A. Homandberg, “Cartilage
chondrolysis by fibronectin fragments is associated with
release of several proteinases: Stromelysin plays a major role
in chondrolysis,” Archives of Biochemistry and Biophysics, vol.
307, no. 1, pp. 110–118, 1994.
[77] M. Del Carlo, D. Schwartz, E. A. Erickson, and R. F.
Loeser, “Endogenous production of reactive oxygen species
is required for stimulation of human articular chondrocyte
matrix metalloproteinase production by fibronectin frag-
ments,” Free Radical Biology and Medicine, vol. 42, no. 9, pp.
1350–1358, 2007.
[78] H. Stanton, L. Ung, and A. J. Fosang, “The 45 kDa
collagen-binding fragment of fibronectin induces matrix
metalloproteinase-13 synthesis by chondrocytes and aggre-
can degradation by aggrecanases,” Biochemical Journal, vol.
364, part 1, pp. 181–190, 2002.
[79] D. Guo, L. Ding, and G. A. Homandberg, “Telopeptides
of type II collagen upregulate proteinases and damage
cartilage but are less eﬀective than highly active fibronectin
fragments,” Inflammation Research, vol. 58, no. 3, pp. 161–
169, 2009.
[80] C. T. G. Appleton, V. Pitelka, J. Henry, and F. Beier,
“Global analyses of gene expression in early experimental
osteoarthritis,” Arthritis and Rheumatism, vol. 56, no. 6, pp.
1854–1868, 2007.
[81] F. Dell’Accio, C. De Bari, N. M. Eltawil, P. Vanhummelen,
and C. Pitzalis, “Identification of the molecular response of
articular cartilage to injury, by microarray screening: Wnt-16
expression and signaling after injury and in osteoarthritis,”
Arthritis and Rheumatism, vol. 58, no. 5, pp. 1410–1421,
2008.
[82] T. Aigner, K. Fundel, J. Saas et al., “Large-scale gene
expression profiling reveals major pathogenetic pathways
of cartilage degeneration in osteoarthritis,” Arthritis and
Rheumatism, vol. 54, no. 11, pp. 3533–3544, 2006.
[83] H. J. Helminen, A. M. Sa¨a¨ma¨nen, H. Salminen, and M. M.
Hyttinen, “Transgenic mouse models for studying the role
of cartilagemacromolecules in osteoarthritis,”Rheumatology,
vol. 41, no. 8, pp. 848–856, 2002.
[84] L. Xu, H. Peng, S. Glasson et al., “Increased expression of
the collagen receptor discoidin domain receptor 2 in articular
cartilage as a key event in the pathogenesis of osteoarthritis,”
Arthritis and Rheumatism, vol. 56, no. 8, pp. 2663–2673,
2007.
[85] M. K. Majumdar, R. Askew, S. Schelling et al., “Double-
knockout of ADAMTS-4 and ADAMTS-5 in mice results in
physiologically normal animals and prevents the progression
of osteoarthritis,” Arthritis and Rheumatism, vol. 56, no. 11,
pp. 3670–3674, 2007.
[86] S. S. Glasson, “In vivo osteoarthritis target validation utiliz-
ing genetically-modified mice,” Current Drug Targets, vol. 8,
no. 2, pp. 367–376, 2007.
[87] T. M. Griﬃn and F. Guilak, “Why is obesity associated
with osteoarthritis? Insights from mouse models of obesity,”
Biorheology, vol. 45, no. 3-4, pp. 387–398, 2008.
[88] P. Pottie, N. Presle, B. Terlain, P. Netter, D. Mainard, and F.
Berenbaum, “Obesity and osteoarthritis: more complex than
predicted!,” Annals of the Rheumatic Diseases, vol. 65, no. 11,
pp. 1403–1405, 2006.
[89] T. M. Griﬃn, B. Fermor, J. L. Huebner et al., “Diet-induced
obesity diﬀerentially regulates behavioral, biomechanical,
and molecular risk factors for osteoarthritis in mice,” Arthri-
tis Research and Therapy, vol. 12, no. 4, p. R130, 2010.
[90] A. Scha¨ﬄer, A. Ehling, E. Neumann et al., “Adipocytokines in
synovial fluid,” Journal of the American Medical Association,
vol. 290, no. 13, pp. 1709–1710, 2003.
[91] N. Presle, P. Pottie, H. Dumond et al., “Diﬀerential distri-
bution of adipokines between serum and synovial fluid in
patients with osteoarthritis. Contribution of joint tissues to
their articular production,” Osteoarthritis and Cartilage, vol.
14, no. 7, pp. 690–695, 2006.
[92] H. Dumond, N. Presle, B. Terlain et al., “Evidence for a key
role of leptin in osteoarthritis,” Arthritis and Rheumatism,
vol. 48, no. 11, pp. 3118–3129, 2003.
14 Arthritis
[93] M. Otero, R. Lago, F. Lago, J. J. Reino, and O. Gualillo,
“Signalling pathway involved in nitric oxide synthase type II
activation in chondrocytes: synergistic eﬀect of leptin with
interleukin-1,” Arthritis Research and Therapy, vol. 7, no. 3,
pp. R581–R591, 2005.
[94] A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen,
and E. Moilanen, “Leptin enhances MMP-1, MMP-3 and
MMP-13 production in human osteoarthritic cartilage and
correlates with MMP-1 and MMP-3 in synovial fluid from
OA patients,” Clinical and Experimental Rheumatology, vol.
29, no. 1, pp. 57–64, 2011.
[95] J. Liang, J. Feng, W. K. Wu et al., “Leptin-mediated cytoskele-
tal remodeling in chondrocytes occurs via the RhoA/ROCK
pathway,” Journal of Orthopaedic Research, vol. 29, no. 3, pp.
369–374, 2011.
[96] J. B. Fitzgerald, M. Jin, D. Dean, D. J. Wood, M. H. Zheng,
and A. J. Grodzinsky, “Mechanical compression of cartilage
explants induces multiple time-dependent gene expression
patterns and involves intracellular calcium and cyclic AMP,”
Journal of Biological Chemistry, vol. 279, no. 19, pp. 19502–
19511, 2004.
[97] M. Murata, L. J. Bonassar, M. Wright, H. J. Mankin, and
C. A. Towle, “A role for the interleukin-1 receptor in the
pathway linking static mechanical compression to decreased
proteoglycan synthesis in surface articular cartilage,” Archives
of Biochemistry and Biophysics, vol. 413, no. 2, pp. 229–235,
2003.
[98] A. Fehrenbacher, E. Steck, M. Rickert, W. Roth, and W.
Richter, “Rapid regulation of collagen but not metallopro-
teinase 1, 3, 13, 14 and tissue inhibitor of metalloproteinase 1,
2, 3 expression in response to mechanical loading of cartilage
explants in vitro,”Archives of Biochemistry and Biophysics, vol.
410, no. 1, pp. 39–47, 2003.
[99] P. M. Ragan, A. M. Badger, M. Cook et al., “Down-
regulation of chondrocyte aggrecan and type-II collagen gene
expression correlates with increases in static compression
magnitude and duration,” Journal of Orthopaedic Research,
vol. 17, no. 6, pp. 836–842, 1999.
[100] P. J. Fanning, G. Emkey, R. J. Smith, A. J. Grodzinsky, N.
Szasz, and S. B. Trippel, “Mechanical regulation of mitogen-
activated protein kinase signaling in articular cartilage,”
Journal of Biological Chemistry, vol. 278, no. 51, pp. 50940–
50948, 2003.
[101] K. W. Li, A. S. Wang, and R. L. Sah, “Microenvironment
regulation of extracellular signal-regulated kinase activity in
chondrocytes: eﬀects of culture configuration, interleukin-1,
and compressive stress,” Arthritis and Rheumatism, vol. 48,
no. 3, pp. 689–699, 2003.
[102] C. Bougault, A. Paumier, E. Aubert-Foucher, and F. Mallein-
Gerin, “Molecular analysis of chondrocytes cultured in
agarose in response to dynamic compression,” BMC Biotech-
nology, vol. 8, article 71, 2008.
[103] L. Ding, E. Heying, N. Nicholson et al., “Mechanical impact
induces cartilage degradation via mitogen activated protein
kinases,” Osteoarthritis and Cartilage, vol. 18, no. 11, pp.
1509–1517, 2010.
[104] J. A. Mengshol, M. P. Vincenti, C. I. Coon, A. Barchowsky,
and C. E. Brinckerhoﬀ, “Interleukin-1 induction of colla-
genase 3 (matrix metalloproteinase 13) gene expression in
chondrocytes requires p38, c-Jun N-terminal kinase, and
nuclear factor kappaB: diﬀerential regulation of collagenase
1 and collagenase 3,” Arthritis and Rheumatism, vol. 43, no.
4, pp. 801–811, 2000.
[105] A. Liacini, J. Sylvester, W. Q. Li et al., “Induction of matrix
metalloproteinase-13 gene expression by TNF-α is mediated
by MAP kinases, AP-1, and NF-κB transcription factors in
articular chondrocytes,” Experimental Cell Research, vol. 288,
no. 1, pp. 208–217, 2003.
[106] M. B. Goldring and S. M. Krane, “Modulation by recombi-
nant interleukin 1 of synthesis of types I and III collagens
and associated procollagen mRNA levels in cultured human
cells,” Journal of Biological Chemistry, vol. 262, no. 34, pp.
16724–16729, 1987.
[107] J. N. A. De Croos, S. S. Dhaliwal, M. D. Grynpas, R. M.
Pilliar, and R. A. Kandel, “Cyclic compressive mechanical
stimulation induces sequential catabolic and anabolic gene
changes in chondrocytes resulting in increased extracellular
matrix accumulation,”Matrix Biology, vol. 25, no. 6, pp. 323–
331, 2006.
[108] M. O. Jortikka, J. J. Parkkinen, R. I. Inkinen et al., “The role
of microtubules in the regulation of proteoglycan synthesis
in chondrocytes under hydrostatic pressure,” Archives of
Biochemistry and Biophysics, vol. 374, no. 2, pp. 172–180,
2000.
[109] J. J. Parkkinen, M. J. Lammi, A. Pelttari, H. J. Helminen, M.
Tammi, and I. Virtanen, “Altered Golgi apparatus in hydro-
statically loaded articular cartilage chondrocytes,” Annals of
the Rheumatic Diseases, vol. 52, no. 3, pp. 192–198, 1993.
[110] E. J. Blain, S. J. Gilbert, A. J. Hayes, and V. C. Duance,
“Disassembly of the vimentin cytoskeleton disrupts articular
cartilage chondrocyte homeostasis,” Matrix Biology, vol. 25,
no. 7, pp. 398–408, 2006.
[111] B. D. Idowu, M. M. Knight, D. L. Bader, and D. A.
Lee, “Confocal analysis of cytoskeletal organisation within
isolated chondrocyte sub-populations cultured in agarose,”
Histochemical Journal, vol. 32, no. 3, pp. 165–174, 2000.
[112] D. A. Lee, M. M. Knight, J. F. Bolton, B. D. Idowu, M. V.
Kayser, and D. L. Bader, “Chondrocyte deformation within
compressed agarose constructs at the cellular and sub-
cellular levels,” Journal of Biomechanics, vol. 33, no. 1, pp. 81–
95, 2000.
[113] D. R. Haudenschild, J. Chen, N. Pang et al., “Vimentin con-
tributes to changes in chondrocyte stiﬀness in osteoarthritis,”
Journal of Orthopaedic Research, vol. 29, no. 1, pp. 20–25,
2011.
[114] W. R. Trickey, T. P. Vail, and F. Guilak, “The role of the
cytoskeleton in the viscoelastic properties of human articular
chondrocytes,” Journal of Orthopaedic Research, vol. 22, no. 1,
pp. 131–139, 2004.
[115] K. Honda, S. Ohno, K. Tanimoto et al., “The eﬀects of high
magnitude cyclic tensile load on cartilage matrix metabolism
in cultured chondrocytes,” European Journal of Cell Biology,
vol. 79, no. 9, pp. 601–609, 2000.
[116] B. Fermor, J. Brice Weinberg, D. S. Pisetsky, M. A. Misukonis,
A. J. Banes, and F. Guilak, “The eﬀects of static and
intermittent compression on nitric oxide production in
articular cartilage explants,” Journal of Orthopaedic Research,
vol. 19, no. 4, pp. 729–737, 2001.
[117] P. Long, R. Gassner, and S. Agarwal, “Tumor necrosis
factor alpha-dependent proinflammatory gene induction is
inhibited by cyclic tensile strain in articular chondrocytes in
vitro,” Arthritis and Rheumatism, vol. 44, no. 10, pp. 2311–
2319, 2001.
[118] M. Lotz, S. Hashimoto, and K. Ku¨hn, “Mechanisms of
chondrocyte apoptosis,” Osteoarthritis and Cartilage, vol. 7,
no. 4, pp. 389–391, 1999.
Arthritis 15
[119] R. Studer, D. Jaﬀurs, M. Stefanovic-Racic, P. D. Robbins, and
C. H. Evans, “Nitric oxide in osteoarthritis,” Osteoarthritis
and Cartilage, vol. 7, no. 4, pp. 377–379, 1999.
[120] J. Martel-Pelletier, N. Alaaeddine, and J. P. Pelletier,
“Cytokines and their role in the pathophysiology of
osteoarthritis,” Frontiers in Bioscience, vol. 4, pp. D694–D703,
1999.
[121] Y. Henrotin, B. Kurz, and T. Aigner, “Oxygen and reactive
oxygen species in cartilage degradation: friends or foes?”
Osteoarthritis and Cartilage, vol. 13, no. 8, pp. 643–654, 2005.
[122] Z. R. Healy, N. H. Lee, X. Gao et al., “Divergent responses
of chondrocytes and endothelial cells to shear stress: cross-
talk among COX-2, the phase 2 response, and apoptosis,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 102, no. 39, pp. 14010–14015, 2005.
[123] J. Borrelli Jr., K. Tinsley, W.M. Ricci, M. Burns, I. E. Karl, and
R. Hotchkiss, “Induction of chondrocyte apoptosis following
impact load,” Journal of Orthopaedic Trauma, vol. 17, no. 9,
pp. 635–641, 2003.
[124] P. Wang, F. Zhu, N. H. Lee, and K. Konstantopoulos, “Shear-
induced interleukin-6 synthesis in chondrocytes: roles of
E prostanoid (EP) 2 and EP3 in cAMP/protein kinase
A- and PI3-K/Akt-dependent NF-κB activation,” Journal of
Biological Chemistry, vol. 285, no. 32, pp. 24793–24804, 2010.
[125] P. Wang, F. Zhu, and K. Konstantopoulos, “Prostaglandin
E2 induces interleukin-6 expression in human chondrocytes
via cAMP/protein kinase A- and phosphatidylinositol 3-
kinase-dependent NF-κB activation,” American Journal of
Physiology, vol. 298, no. 6, pp. 1445–1456, 2010.
[126] F. Zhu, P. Wang, N. H. Lee, M. B. Goldring, and K.
Konstantopoulos, “Prolonged application of high fluid shear
to chondrocytes recapitulates gene expression profiles associ-
ated with osteoarthritis,” PLoS ONE, vol. 5, no. 12, Article ID
e15174, 2010.
[127] P. M. Lin, C. T. C. Chen, and P. A. Torzilli, “Increased
stromelysin-1 (MMP-3), proteoglycan degradation (3B3-
and 7D4) and collagen damage in cyclically load-injured
articular cartilage,” Osteoarthritis and Cartilage, vol. 12, no.
6, pp. 485–496, 2004.
[128] J. Steinmeyer and B. Ackermann, “The eﬀect of continu-
ously applied cyclic mechanical loading on the fibronectin
metabolism of articular cartilage explants,” Research in
Experimental Medicine, vol. 198, no. 5, pp. 247–260, 1999.
[129] S. Madhavan, M. Anghelina, B. Rath-Deschner et al.,
“Biomechanical signals exert sustained attenuation of proin-
flammatory gene induction in articular chondrocytes,”
Osteoarthritis and Cartilage, vol. 14, no. 10, pp. 1023–1032,
2006.
[130] R. Gassner, M. J. Buckley, H. Georgescu et al., “Cyclic tensile
stress exerts anti-inflammatory actions on chondrocytes
by inhibiting inducible nitric oxide synthase,” Journal of
Immunology, vol. 163, pp. 2187–2192, 1999.
[131] Z. Xu, M. J. Buckley, C. H. Evans, and S. Agarwal, “Cyclic
tensile strain acts as an antagonist of IL-1 beta actions in
chondrocytes,” Journal of Immunology, vol. 165, pp. 453–460,
2000.
[132] T. T. Chowdhury, D. L. Bader, and D. A. Lee, “Dynamic com-
pression inhibits the synthesis of nitric oxide and PGE2 by IL-
1β stimulated chondrocytes cultured in agarose constructs,”
Biochemical and Biophysical Research Communications, vol.
285, pp. 1168–1174, 2001.
[133] T. T. Chowdhury, S. Arghandawi, J. Brand et al., “Dynamic
compression counteracts IL-1β induced inducible nitric
oxide synthase and cyclo-oxygenase-2 expression in chon-
drocyte/agarose constructs,” Arthritis Research and Therapy,
vol. 10, no. 2, article no. R35, 2008.
[134] O. O. Akanji, P. Sakthithasan, D. M. Salter, and T. T. Chowd-
hury, “Dynamic compression alters NFkappaB activation
and IkappaB-alpha expression in IL-1beta-stimulated chon-
drocyte/agarose constructs,” Inflammation Research, vol. 59,
no. 1, pp. 41–52, 2010.
[135] S. Agarwal, J. Deschner, P. Long et al., “Role of NF-
kappaB transcription factors in anti-inflammatory and pro-
inflammatory actions of mechanical signals,” Arthritis and
Rheumatism, vol. 50, pp. 3541–3548, 2004.
[136] S. J. Millward-Sadler, M. O.Wright, H. S. Lee et al., “Integrin-
regulated secretion of interleukin 4: a novel pathway of
mechanotransduction in human articular chondrocytes,”
Journal of Cell Biology, vol. 145, no. 1, pp. 183–189, 1999.
[137] S. J. Millward-Sadler, N. S. Khan, M. G. Bracher, M.
O. Wright, and D. M. Salter, “Roles for the interleukin-
4 receptor and associated JAK/STAT proteins in human
articular chondrocyte mechanotransduction,” Osteoarthritis
and Cartilage, vol. 14, no. 10, pp. 991–1001, 2006.
[138] D. M. Salter, S. J. Millward-Sadler, G. Nuki, and M. O.
Wright, “Integrin-interleukin-4 mechanotransduction path-
ways in human chondrocytes,” Clinical Orthopaedics and
Related Research, no. 391, pp. S49–S60, 2001.
[139] T. T. Chowdhury, D. M. Salter, D. L. Bader, and D. A.
Lee, “Integrin-mediated mechanotransduction processes in
TGFβ-stimulated monolayer-expanded chondrocytes,” Bio-
chemical and Biophysical Research Communications, vol. 318,
no. 4, pp. 873–881, 2004.
[140] T. T. Chowdhury, R. N. Appleby, D. M. Salter, D. A. Bader,
and D. A. Lee, “Integrin-mediated mechanotransduction in
IL-1β stimulated chondrocytes,” Biomechanics and Modeling
in Mechanobiology, vol. 5, no. 2-3, pp. 192–201, 2006.
[141] M. O. Wright, K. Nishida, C. Bavington et al., “Hyperpo-
larisation of cultured human chondrocytes following cyclical
pressure-induced strain: evidence of a role for α5β1 integrin
as a chondrocyte mechanoreceptor,” Journal of Orthopaedic
Research, vol. 15, no. 5, pp. 742–747, 1997.
[142] H. S. Lee, S. J. Millward-Sadler, M. O. Wright, G. Nuki,
and D. M. Salter, “Integrin and mechanosensitive ion
channel-dependent tyrosine phosphorylation of focal adhe-
sion proteins and β-catenin in human articular chondrocytes
after mechanical stimulation,” Journal of Bone and Mineral
Research, vol. 15, no. 8, pp. 1501–1509, 2000.
[143] M. M. Knight, T. Toyoda, D. A. Lee, and D. L. Bader,
“Mechanical compression and hydrostatic pressure induce
reversible changes in actin cytoskeletal organisation in chon-
drocytes in agarose,” Journal of Biomechanics, vol. 39, no. 8,
pp. 1547–1551, 2006.
[144] T. T. Chowdhury, D. L. Bader, and D. A. Lee, “Anti-
inflammatory eﬀects of IL-4 and dynamic compression in
IL-1β stimulated chondrocytes,” Biochemical and Biophysical
Research Communications, vol. 339, no. 1, pp. 241–247, 2006.
[145] H. Doi, K. Nishida, M. Yorimitsu et al., “Interleukin-
4 downregulates the cyclic tensile stress-induced matrix
metalloproteinases-13 and cathepsin b expression by rat
normal chondrocytes,” Acta Medica Okayama, vol. 62, no. 2,
article 7, pp. 119–126, 2008.
[146] T. Vincent, M. Hermansson, M. Bolton, R. Wait, and J.
Saklatvala, “Basic FGF mediates an immediate response of
articular cartilage to mechanical injury,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 99, no. 12, pp. 8259–8264, 2002.
16 Arthritis
[147] T. L. Vincent, C. J. McLean, L. E. Full, D. Peston, and J.
Saklatvala, “FGF-2 is bound to perlecan in the pericellular
matrix of articular cartilage, where it acts as a chondrocyte
mechanotransducer,”Osteoarthritis and Cartilage, vol. 15, no.
7, pp. 752–763, 2007.
[148] M. O. Wright, K. Nishida, C. Bavington et al., “Hyperpo-
larisation of cultured human chondrocytes following cyclical
pressure-induced strain: evidence of a role for alpha 5 beta
1 integrin as a chondrocyte mechanoreceptor,” Journal of
Orthopaedic Research, vol. 15, no. 5, pp. 742–747, 1997.
[149] W. B. Valhmu and F. J. Raia, “myo-inositol 1,4,5-
trisphosphate and Ca2+/calmodulin-dependent factors
mediate transduction of compression-induced signals in
bovine articular chondrocytes,” Biochemical Journal, vol.
361, part 3, pp. 689–696, 2002.
[150] Y. Geng and M. Lotz, “Increased intracellular Ca2+ selec-
tively suppresses IL-1-induced NO production by reducing
iNOS mRNA stability,” Journal of Cell Biology, vol. 129, no. 6,
pp. 1651–1657, 1995.
[151] S. J. Millward-Sadler, M. O.Wright, P. W. Flatman, and D. M.
Salter, “ATP in the mechanotransduction pathway of normal
human chondrocytes,” Biorheology, vol. 41, no. 3-4, pp. 567–
575, 2004.
[152] T. T. Chowdhury and M. M. Knight, “Purinergic pathway
suppresses the release of NO and stimulates proteoglycan
synthesis in chondrocyte/agarose constructs subjected to
dynamic compression,” Journal of Cellular Physiology, vol.
209, no. 3, pp. 845–853, 2006.
[153] H. Yokota, M. B. Goldring, and H. B. Sun, “CITED2-
mediated regulation of MMP-1 and MMP-13 in human
chondrocytes under flow shear,” Journal of Biological Chem-
istry, vol. 278, no. 47, pp. 47275–47280, 2003.
[154] D. J. Leong, Y. H. Li, X. I. Gu et al., “Physiological loading
of joints prevents cartilage degradation through CITED2,”
FASEB Journal, vol. 25, no. 1, pp. 182–191, 2011.
[155] N. Gerwin, C. Hops, and A. Lucke, “Intraarticular drug
delivery in osteoarthritis,” Advanced Drug Delivery Reviews,
vol. 58, no. 2, pp. 226–242, 2006.
[156] J. P. Caron, J. C. Fernandes, J. Martel-Pelletier et al.,
“Chondroprotective eﬀect of intraarticular injections
of interleukin-1 receptor antagonist in experimental
osteoarthritis: suppression of collagenase-1 expression,”
Arthritis and Rheumatism, vol. 39, no. 9, pp. 1535–1544,
1996.
[157] M. Yorimitsu, K. Nishida, A. Shimizu et al., “Intra-articular
injection of interleukin-4 decreases nitric oxide production
by chondrocytes and ameliorates subsequent destruction
of cartilage in instability-induced osteoarthritis in rat knee
joints,” Osteoarthritis and Cartilage, vol. 16, no. 7, pp. 764–
771, 2008.
[158] M. Jin, G. R. Emkey, P. Siparsky, S. B. Trippel, and A.
J. Grodzinsky, “Combined eﬀects of dynamic tissue shear
deformation and insulin-like growth factor I on chondrocyte
biosynthesis in cartilage explants,” Archives of Biochemistry
and Biophysics, vol. 414, no. 2, pp. 223–231, 2003.
[159] E. G. Lima, L. Bian, K. W. Ng et al., “The beneficial
eﬀect of delayed compressive loading on tissue-engineered
cartilage constructs cultured with TGF-β3,” Osteoarthritis
and Cartilage, vol. 15, no. 9, pp. 1025–1033, 2007.
[160] I. C. Helmark, U. R. Mikkelsen, J. Borglum et al., “Exercise
increases interleukin-10 levels both intraarticularly and peri-
synovially in patients with knee osteoarthritis: a randomized
controlled trial,” Arthritis Research and Therapy, p. R126,
2010.
[161] M. Anghelina, D. Sjostrom, P. Perera, J. Nam, T. Knobloch,
and S. Agarwal, “Regulation of biomechanical signals by NF-
κB transcription factors in chondrocytes,” Biorheology, vol.
45, no. 3-4, pp. 245–256, 2008.
[162] P. M. Perera, E. Wypasek, S. Madhavan et al., “Mechanical
signals control Sox-9, Vegf and c-Myc expression and
cell proliferation during inflammation via integrin-linked
kinase, B-Raf, and ERK 1/2-dependent signaling in articular
chondrocytes,” Arthritis Research and Therapy, vol. 12, no. 3,
p. R106, 2010.
[163] F. Bao, Y. Chen, K. A. Schneider, and L. C. Weaver, “An
integrin inhibiting molecule decreases oxidative damage and
improves neurological function after spinal cord injury,”
Experimental Neurology, vol. 214, no. 2, pp. 160–167, 2008.
[164] D. M. Salter, M. O. Wright, and S. J. Millward-Sadler,
“NMDA receptor expression and roles in human articular
chondrocyte mechanotransduction,” Biorheology, vol. 41, no.
3-4, pp. 273–281, 2004.
[165] L. Ramage, M. A. Martel, G. E. Hardingham, and D.
M. Salter, “NMDA receptor expression and activity in
osteoarthritic human articular chondrocytes,” Osteoarthritis
and Cartilage, vol. 16, no. 12, pp. 1576–1584, 2008.
[166] S. R. McGlashan, E. C. Cluett, C. G. Jensen, and C. A.
Poole, “Primary Cilia in osteoarthritic chondrocytes: from
chondrons to clusters,” Developmental Dynamics, vol. 237,
no. 8, pp. 2013–2020, 2008.
[167] M. Garcia and M. M. Knight, “Cyclic loading opens
hemichannels to release ATP as part of a chondro-
cyte mechanotransduction pathway,” Journal of Orthopaedic
Research, vol. 28, no. 4, pp. 510–515, 2010.
[168] Y. Xing, Y. Gu, R. R. Gomes Jr., and J. You, “P2Y(2) receptors
and GRK2 are involved in oscillatory fluid flow induced
ERK1/2 responses in chondrocytes,” Journal of Orthopaedic
Research, vol. 29, no. 6, pp. 828–833, 2011.
[169] D. M. Salter, S. J. Millward-Sadler, G. Nuki, and M. O.
Wright, “Diﬀerential responses of chondrocytes from normal
and osteoarthritic human articular cartilage to mechanical
stimulation,” Biorheology, vol. 39, no. 1-2, pp. 97–108, 2002.
[170] S. J. Millward-Sadler, M. O. Wright, H. S. Lee, H. Caldwell,
G. Nuki, and D. M. Salter, “Altered electrophysiological
responses tomechanical stimulation and abnormal signalling
through α5β1 integrin in chondrocytes from osteoarthritic
cartilage,” Osteoarthritis and Cartilage, vol. 8, no. 4, pp. 272–
278, 2000.
